about
Do inflammatory bowel disease therapies cause cancer?Belatacept: a new biologic and its role in kidney transplantation.Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockadePost-transplant lymphoproliferative disorder: case report and review of susceptibility to EBV in the Scottish adult renal transplant pool.Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients.Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?Belatacept utilization recommendations: an expert position.Risk evaluation and mitigation strategies: a focus on belatacept.Opportunistic viral infections in intestinal transplantation.Post-transplant lymphoproliferative disorder presenting as a tumor adjacent to the renal allograft: A case report and review of the literature.A virus-like particle-based Epstein-Barr virus vaccine.Use of Foscarnet Therapy for EBV Infection following Control of PTLD with Enhancement of Cellular Immunity in a Lung-Transplant Recipient.Post-transplant lymphoproliferative disorder in an adolescent masquerading as a complicated primary EBV infection.Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).Risk of Lymphoma in Inflammatory Bowel Disease.Adoptive cell therapy against EBV-related malignancies: a survey of clinical results
P2860
Q34613890-76A56B92-C1AD-4387-A4C0-F46D0F097524Q34634807-F4B8A634-F03F-4B34-A8C3-18F1F21D5888Q34976218-CFB785E7-38A3-4C1E-957B-08D626AB9B66Q35574186-F1752DD9-6556-403A-B028-23BB661EDF83Q37152749-1CC91AD2-6858-4AC2-8ACF-2408A9C7A0F3Q37767556-78A0D548-E633-4A9D-9804-AEECB1608DF7Q38064538-02BC47CD-9100-465C-A2F6-A9B6FC75808EQ38085439-EE941113-784B-4B92-97D7-C25CE550B347Q38097119-3C6A2F4B-012E-4D90-9870-4C3F4C806EDCQ38264424-F519C7AF-82A4-4953-B180-2A9D76D508E8Q39458965-F792135C-CF87-444E-A015-8A128DD0F27AQ41929024-D86E2BFE-B54F-400E-9E40-AB77FB8E45ACQ42582483-D4950FAD-FD24-4F66-B8C4-EFFA6F94D1E1Q48199876-5C6A87C6-AAF5-45EE-A0F1-063E5275BE53Q55533554-54C68C1B-3A3A-4F38-93A3-30E5FB1CE20BQ57056125-97FBC772-BFD9-495F-BA02-4A0659F5C8D4
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Posttransplant lymphoproliferative disorder.
@en
type
label
Posttransplant lymphoproliferative disorder.
@en
prefLabel
Posttransplant lymphoproliferative disorder.
@en
P2093
P356
P1476
Posttransplant lymphoproliferative disorder.
@en
P2093
Donald E Tsai
Jennifer Trofe
Matthew J Everly
Roy D Bloom
P304
P356
10.1345/APH.1G706
P407
P577
2007-10-16T00:00:00Z